TY - JOUR
T1 - Lipid-tagged antibodies
T2 - Bacterial expression and characterization of a lipoprotein-single-chain antibody fusion protein
AU - Laukkanen, Marja-Leena
AU - Teeri, Tuula
AU - Keinänen, Kari
N1 - Project code: BIO1006
PY - 1993
Y1 - 1993
N2 - In order to achieve a stable and functional
immobilization of antibodies, we investigated the possibility of adding
hydrophobic membrane anchors to antibody fragments expressed in Escherichia coli. The DNA sequence encoding the signal peptide and the nine N-terminal amino add residues of the major lipoprotein of E.coli was fused to the sequence of an anti-2-phenyloxazolone single-chain Fv antibody fragment [Takkinen et al. (1991) Protein Engng, 4, 837–841]. The expression of the fusion construct in E.coli
resulted in specific accumulation of an immunoreactive 28 kDa
polypeptide. Unlike the unmodified single-chain Fv fragment, the fusion
protein was cell-associated, labelled by [3H]palmitate which
is indicative of the presence of N-terminal lipid modification,
partitioned into the detergent phase upon Triton X-114 phase separation
and was localized predominantly in the bacterial outer membrane. The
fusion antibody displayed specific 2-phenyloxazolone-binding activity in
the membranebound form and after solubilization with non-ionic
detergents. Furthermore, upon removal of detergent the fusion antibody
was incorporated into proteoliposomes which displayed specific
hapten-binding activity. Our results show that antibodies can be
converted to membrane-bound proteins with retention of antigen-binding
properties by introduction of lipid anchors during biosynthesis. This
approach may prove useful in the design of immunoliposomes and
immunosensors.
AB - In order to achieve a stable and functional
immobilization of antibodies, we investigated the possibility of adding
hydrophobic membrane anchors to antibody fragments expressed in Escherichia coli. The DNA sequence encoding the signal peptide and the nine N-terminal amino add residues of the major lipoprotein of E.coli was fused to the sequence of an anti-2-phenyloxazolone single-chain Fv antibody fragment [Takkinen et al. (1991) Protein Engng, 4, 837–841]. The expression of the fusion construct in E.coli
resulted in specific accumulation of an immunoreactive 28 kDa
polypeptide. Unlike the unmodified single-chain Fv fragment, the fusion
protein was cell-associated, labelled by [3H]palmitate which
is indicative of the presence of N-terminal lipid modification,
partitioned into the detergent phase upon Triton X-114 phase separation
and was localized predominantly in the bacterial outer membrane. The
fusion antibody displayed specific 2-phenyloxazolone-binding activity in
the membranebound form and after solubilization with non-ionic
detergents. Furthermore, upon removal of detergent the fusion antibody
was incorporated into proteoliposomes which displayed specific
hapten-binding activity. Our results show that antibodies can be
converted to membrane-bound proteins with retention of antigen-binding
properties by introduction of lipid anchors during biosynthesis. This
approach may prove useful in the design of immunoliposomes and
immunosensors.
U2 - 10.1093/protein/6.4.449
DO - 10.1093/protein/6.4.449
M3 - Article
SN - 1741-0126
VL - 6
SP - 449
EP - 454
JO - Protein Engineering, Design and Selection
JF - Protein Engineering, Design and Selection
IS - 4
ER -